3 days ago
Lisa Vanderpump's nephew, Sam Vanderpump, recently opened up about his ongoing health struggles. The 29-year-old Made in Chelsea star shared that he is still awaiting a liver transplant following his diagnosis of end-stage liver disease.
Sam announced his diagnosis publicly in October 2025. The announcement came months after he suffered severe liver and kidney failure following sepsis in December 2024. In an Instagram post, he shared that he "lives with a genetic liver condition and polycystic kidney disease (PKD)."
While appearing on the October 7 episode of Good Morning Britain, Sam said, "When I was first told that I needed a transplant, they said maybe [in] the next two years I'd have a transplant. I think we're already a year down the line, and luckily my health hasn't deteriorated. But that is the fear."
The reality star, who dyed his hair pink to raise awareness about organ donation, said he has received an overwhelming response from fans. However, he clarified that getting a transplant is not that simple. Sam explained that organ donation follows a "certain procedure" that he cannot arrange himself.
"So if someone were interested in being a live donor for me, they would have to contact the hospital, King's College Hospital, and go through that route themselves," he added. "So, it's kind of like you're caught between a rock and a hard place. You want to get further up the list, but you don't want your health to deteriorate."
#Health #hospital
Sam announced his diagnosis publicly in October 2025. The announcement came months after he suffered severe liver and kidney failure following sepsis in December 2024. In an Instagram post, he shared that he "lives with a genetic liver condition and polycystic kidney disease (PKD)."
While appearing on the October 7 episode of Good Morning Britain, Sam said, "When I was first told that I needed a transplant, they said maybe [in] the next two years I'd have a transplant. I think we're already a year down the line, and luckily my health hasn't deteriorated. But that is the fear."
The reality star, who dyed his hair pink to raise awareness about organ donation, said he has received an overwhelming response from fans. However, he clarified that getting a transplant is not that simple. Sam explained that organ donation follows a "certain procedure" that he cannot arrange himself.
"So if someone were interested in being a live donor for me, they would have to contact the hospital, King's College Hospital, and go through that route themselves," he added. "So, it's kind of like you're caught between a rock and a hard place. You want to get further up the list, but you don't want your health to deteriorate."
#Health #hospital
4 days ago
Christa Pike is feeling "angry and confused" after waking up in the hospital in the wake of a failed execution attempt that left her with severe physical health challenges that put her on a "long road to recovery," her attorneys said on Wednesday.
Pike had been unconscious and in critical condition in the days after two doses of pentobarbital failed to end her life on Sept. 30, they said.
"On Monday night, it was our understanding that Christa was brain-dead and that life support would be removed the next day," Randy Spivey, a member of her legal team, said during a press conference Wednesday afternoon. "But on Tuesday, to the shock of everyone … Christa woke up and began talking."
Spivey said the effects of the pentobarbital have caused her to develop a blood clot, pneumonia and left her arms and hands "tremendously swollen," to the point where she's not currently able to use them. He added that Pike is still dealing with significant "cognitive confusion," but is "very aware" that the state had tried and failed to end her life.
The press conference came shortly after a hearing in which a judge granted Pike's attorneys' request to order the state to preserve all evidence connected to the execution, including medical equipment, communications related to the decision to call off the procedure or related to her emergency care and "anything that was in the actual room." The judge also ordered that any "barriers" that may prevent Pike from communicating with her attorneys while she's in the hospital be removed.
#attorneys #execution
Pike had been unconscious and in critical condition in the days after two doses of pentobarbital failed to end her life on Sept. 30, they said.
"On Monday night, it was our understanding that Christa was brain-dead and that life support would be removed the next day," Randy Spivey, a member of her legal team, said during a press conference Wednesday afternoon. "But on Tuesday, to the shock of everyone … Christa woke up and began talking."
Spivey said the effects of the pentobarbital have caused her to develop a blood clot, pneumonia and left her arms and hands "tremendously swollen," to the point where she's not currently able to use them. He added that Pike is still dealing with significant "cognitive confusion," but is "very aware" that the state had tried and failed to end her life.
The press conference came shortly after a hearing in which a judge granted Pike's attorneys' request to order the state to preserve all evidence connected to the execution, including medical equipment, communications related to the decision to call off the procedure or related to her emergency care and "anything that was in the actual room." The judge also ordered that any "barriers" that may prevent Pike from communicating with her attorneys while she's in the hospital be removed.
#attorneys #execution
4 days ago
Wynonna Judd is candidly addressing becoming a grandmother again amid her painful separation from her daughter, Grace Kelley, as well as her legal troubles and substance abuse struggles.
The country music star discussed her complex family dynamic as her daughter serves a 15-month jail sentence in Virginia following a felony conviction.
Wynonna has also previously opened up about navigating grief following the death of her mother, Naomi, who passed away by suicide in 2022.
ZUMAPRESS.com / MEGA
In an interview, Wynonna revealed that her daughter, Kelley, severed all communication with her a year ago while battling severe substance addiction.
#daughter #substance #following
The country music star discussed her complex family dynamic as her daughter serves a 15-month jail sentence in Virginia following a felony conviction.
Wynonna has also previously opened up about navigating grief following the death of her mother, Naomi, who passed away by suicide in 2022.
ZUMAPRESS.com / MEGA
In an interview, Wynonna revealed that her daughter, Kelley, severed all communication with her a year ago while battling severe substance addiction.
#daughter #substance #following
5 days ago
Christa Pike is conscious and speaking in the hospital after surviving Tennessee's attempt to execute her last week, her lawyers said Tuesday.
"Against all odds, Christa Pike is conscious, speaking, and continues to receive critical medical care. Despite the severe damage she endured to her arms, she is still handcuffed and shackled to the bed. Her recovery is medically unprecedented. Her prognosis remains unclear but, at a minimum, we expect a long recovery," her legal team wrote in a statement released to the media.
Pike had been unconscious and in critical condition in the days after two doses of pentobarbital failed to end her life on Wednesday, Sept. 30, according to her attorneys.
Dr. Joel Zivot, a medical expert who has consulted with Pike's legal team, told the **** ociated Press that the latest update "bodes well for a good recovery," but said that the full picture of her long-term health won't be clear for some time.
"She has recovered to a certain degree that she's able to be off a ventilator and able to speak, but in no way would I announce her free of further serious risk," he said. "There's still a lot of bad things that can happen here."
#recovery #speaking
"Against all odds, Christa Pike is conscious, speaking, and continues to receive critical medical care. Despite the severe damage she endured to her arms, she is still handcuffed and shackled to the bed. Her recovery is medically unprecedented. Her prognosis remains unclear but, at a minimum, we expect a long recovery," her legal team wrote in a statement released to the media.
Pike had been unconscious and in critical condition in the days after two doses of pentobarbital failed to end her life on Wednesday, Sept. 30, according to her attorneys.
Dr. Joel Zivot, a medical expert who has consulted with Pike's legal team, told the **** ociated Press that the latest update "bodes well for a good recovery," but said that the full picture of her long-term health won't be clear for some time.
"She has recovered to a certain degree that she's able to be off a ventilator and able to speak, but in no way would I announce her free of further serious risk," he said. "There's still a lot of bad things that can happen here."
#recovery #speaking
7 days ago
Chuck Lorre ignited a feud with White House after a charity gala speech put Donald Trump on notice.
Lorre lamented that while he'd love to champion a "compassionate government," he instead feels compelled to "say a few words about that bloated orange piece of s--- in the White House."
A spokesperson for the White House responded, encouraging Lorre to "immediately seek psychiatric help to treat his severe case of Trump Derangement Syndrome."
Add Chuck Lorre to the overstuffed rolodex of Hollywood legends who have personal beef with Donald Trump.
The creator of such modern classics as The Big Bang Theory and Two and a Half Men took no prisoners in his acceptance speech after winning the Founders Award at a Project Angel Food fundraiser in Los Angeles on Sept. 26. "Sure, I'd love to stand here and talk about my deep yearning for a more compassionate government, one that prioritizes the health and welfare of its citizens," he lamented. "But the burden of my profession demands that I take this opportunity to say a few words about that bloated orange piece of s--- in the White House" (per The Daily Beast).
#lorre #speech #compassionate
Lorre lamented that while he'd love to champion a "compassionate government," he instead feels compelled to "say a few words about that bloated orange piece of s--- in the White House."
A spokesperson for the White House responded, encouraging Lorre to "immediately seek psychiatric help to treat his severe case of Trump Derangement Syndrome."
Add Chuck Lorre to the overstuffed rolodex of Hollywood legends who have personal beef with Donald Trump.
The creator of such modern classics as The Big Bang Theory and Two and a Half Men took no prisoners in his acceptance speech after winning the Founders Award at a Project Angel Food fundraiser in Los Angeles on Sept. 26. "Sure, I'd love to stand here and talk about my deep yearning for a more compassionate government, one that prioritizes the health and welfare of its citizens," he lamented. "But the burden of my profession demands that I take this opportunity to say a few words about that bloated orange piece of s--- in the White House" (per The Daily Beast).
#lorre #speech #compassionate
9 days ago
Porizkova says working out regularly has helped ease her severe anxiety and made her stronger
The model began working out in her 40s and now has a personal trainer
She said she and husband Jeff Greenstein feel stronger than ever in their 60s after prioritizing fitness
Paulina Porizkova is opening up about the "unexpected benefit" of hitting the gym.
On Thursday, Oct. 1, the 61-year-old supermodel posted a video on Instagram documenting her workout routine. She told fans that she's "never felt better about inhabiting my body," but staying on top of her fitness wasn't always a priority.
#thursday
The model began working out in her 40s and now has a personal trainer
She said she and husband Jeff Greenstein feel stronger than ever in their 60s after prioritizing fitness
Paulina Porizkova is opening up about the "unexpected benefit" of hitting the gym.
On Thursday, Oct. 1, the 61-year-old supermodel posted a video on Instagram documenting her workout routine. She told fans that she's "never felt better about inhabiting my body," but staying on top of her fitness wasn't always a priority.
#thursday
9 days ago
Hollywood icon Judi Dench is speaking out against retail giant Petco over alleged mistreatment of birds.
The 91-year-old Oscar winner sprang into action after watching a PETA investigation depicting disturbing conditions at a "mass breeding factory in Petco's supply chain."
Page Six Hollywood reported Friday, October 2, that Dench did not mince words in a letter to Petco CEO Joel Anderson.
"The footage revealed that thousands of parakeets were confined to cramped, filthy cages with no opportunity to fly, explore, or engage in the natural behaviors that make them who they are," Dench wrote in part, per the outlet. "Some birds suffered severe injuries, including a bird who had lost an eye and a chick whose wing had shriveled, blackened, and fallen off."
ZUMAPRESS.com / MEGA
#petco #peta #page
The 91-year-old Oscar winner sprang into action after watching a PETA investigation depicting disturbing conditions at a "mass breeding factory in Petco's supply chain."
Page Six Hollywood reported Friday, October 2, that Dench did not mince words in a letter to Petco CEO Joel Anderson.
"The footage revealed that thousands of parakeets were confined to cramped, filthy cages with no opportunity to fly, explore, or engage in the natural behaviors that make them who they are," Dench wrote in part, per the outlet. "Some birds suffered severe injuries, including a bird who had lost an eye and a chick whose wing had shriveled, blackened, and fallen off."
ZUMAPRESS.com / MEGA
#petco #peta #page
10 days ago
Ashley Tisdale French says postpartum depression and anxiety strained her marriage after daughter Jupiter's birth
She says a doctor did not diagnose her postpartum depression until Jupiter was 2
Tisdale French experienced less severe symptoms after welcoming her second daughter Emerson
Ashley Tisdale French is getting candid about her experience with postpartum depression.
In the first episode of her husband Christopher French's new podcast Recovering, the actress and mom of two, 41, spoke about her struggles with postpartum depression after giving birth to her older daughter, Jupiter, now 5. Tisdale French shared that the experience placed stress on her marriage.
#french
She says a doctor did not diagnose her postpartum depression until Jupiter was 2
Tisdale French experienced less severe symptoms after welcoming her second daughter Emerson
Ashley Tisdale French is getting candid about her experience with postpartum depression.
In the first episode of her husband Christopher French's new podcast Recovering, the actress and mom of two, 41, spoke about her struggles with postpartum depression after giving birth to her older daughter, Jupiter, now 5. Tisdale French shared that the experience placed stress on her marriage.
#french
12 days ago
An ancient ground carving that was severely damaged by the administration’s border wall construction was created before Stonehenge and Egypt’s oldest pyramid, according to recently publicized research.
The Las Playas Intaglio, a giant fish carved into the Sonoran Desert in Arizona, is now considered the oldest example in the Americas of a geoglyphic, the ancient art form that is carved into or drawn on the ground.
In April, contractors hired by the Trump administration to make way for a second wall along the Arizona-Mexico border “scraped” a 50-foot swath through the ancient carving, according to the Center for Biological Diversity, which documented the damage.
The intaglio on the ground of the ancestral homeland of the Tohono O’odham and other Indigenous tribes is estimated to be about 2,000 years older than Egypt’s first pyramid and to have been created about 1,500 years before the first construction of Stonehenge and 4,000 years before Peru’s Nazca Lines, researchers have found.
The formerly 272-foot carving had originally been thought to be about 1,000 years old. But the latest research dates the art’s creation to at least 6,500 years ago, and possibly as much as 7,500 years ago.
#years #ground #stonehenge #border
The Las Playas Intaglio, a giant fish carved into the Sonoran Desert in Arizona, is now considered the oldest example in the Americas of a geoglyphic, the ancient art form that is carved into or drawn on the ground.
In April, contractors hired by the Trump administration to make way for a second wall along the Arizona-Mexico border “scraped” a 50-foot swath through the ancient carving, according to the Center for Biological Diversity, which documented the damage.
The intaglio on the ground of the ancestral homeland of the Tohono O’odham and other Indigenous tribes is estimated to be about 2,000 years older than Egypt’s first pyramid and to have been created about 1,500 years before the first construction of Stonehenge and 4,000 years before Peru’s Nazca Lines, researchers have found.
The formerly 272-foot carving had originally been thought to be about 1,000 years old. But the latest research dates the art’s creation to at least 6,500 years ago, and possibly as much as 7,500 years ago.
#years #ground #stonehenge #border
23 days ago
In late 2022, OpenAI released ChatGPT, and within months the bottom rung of the tech-industry career ladder started to disappear. Graduates who majored in computer science and other AI-exposed fields are increasingly missing out on the jobs they trained for, and a chunk of them are landing behind restaurant counters and retail registers instead, according to two Census Bureau papers.
An April 2026 Census paper tracked matched employer-employee records and found that hiring of workers ages 22 to 24 fell sharply in the industries most exposed to AI, while hiring in less-exposed industries held steady. Employment for early-career workers in the most AI-exposed fifth of industries dropped 12% over the ten quarters after ChatGPT's release. Lee Tucker, one of the coauthors of the paper, said "the decline in hires is the primary cause" of that rate of unemployment, not people losing jobs they already had.
That mattered most for one type of graduate. The most AI-exposed industries, Tucker found, cluster heavily around software and information-technology work, which are the very fields computer science and other highly AI-exposed majors are built to feed into.
A second paper from last week, also coauthored by Tucker, follows the graduates of the most AI-exposed decile of college majors. Their odds of holding a job one quarter after graduation fell by five percentage points, and full-quarter initial earnings dropped 13% following ChatGPT's release. A 13% earnings decline is roughly the size economists would expect from graduating into a severe recession—except there wasn't one, since the rest of the labor market held up fine.
Young grads still need to work and still have jobs, even if they've received highly exposed degrees. So the decline in earnings is less about a lack of employment and more about pursuing lower-wage occupations to make ends meet.
#graduates
An April 2026 Census paper tracked matched employer-employee records and found that hiring of workers ages 22 to 24 fell sharply in the industries most exposed to AI, while hiring in less-exposed industries held steady. Employment for early-career workers in the most AI-exposed fifth of industries dropped 12% over the ten quarters after ChatGPT's release. Lee Tucker, one of the coauthors of the paper, said "the decline in hires is the primary cause" of that rate of unemployment, not people losing jobs they already had.
That mattered most for one type of graduate. The most AI-exposed industries, Tucker found, cluster heavily around software and information-technology work, which are the very fields computer science and other highly AI-exposed majors are built to feed into.
A second paper from last week, also coauthored by Tucker, follows the graduates of the most AI-exposed decile of college majors. Their odds of holding a job one quarter after graduation fell by five percentage points, and full-quarter initial earnings dropped 13% following ChatGPT's release. A 13% earnings decline is roughly the size economists would expect from graduating into a severe recession—except there wasn't one, since the rest of the labor market held up fine.
Young grads still need to work and still have jobs, even if they've received highly exposed degrees. So the decline in earnings is less about a lack of employment and more about pursuing lower-wage occupations to make ends meet.
#graduates
23 days ago
Evommune, Inc. (NYSE:EVMN) announced on September 8 that EVO756 missed its primary endpoint in a randomized, double-blind, placebo-controlled Phase 2b trial involving 121 adults with moderate-to-severe atopic dermatitis. The primary measure was the percentage change from baseline in Eczema Area and Severity Index, or EASI, at week 12. No tested dose met the primary or secondary endpoints, and development in that indication will stop.
Evommune, Inc. (NYSE:EVMN) had already discontinued EVO756 for chronic spontaneous urticaria following a June trial failure. Development continues in migraine prevention. The setbacks place greater weight on EVO301, which has positive Phase 2a eczema data and a Phase 2b study planned for mid-2027.
Evommune, Inc. (NYSE:EVMN) has clinical evidence supporting its next eczema program. In February, the company reported that EVO301 met the primary endpoint in a randomized, double-blind, placebo-controlled Phase 2a trial involving 70 adults. Participants received two intravenous doses or placebo over a 12-week study.
Evommune, Inc. (NYSE:EVMN) reported a 55% EASI reduction with EVO301 versus 22% with placebo at week 12, a difference of 33 percentage points. The study met its prespecified Bayesian success criterion, and a separate conventional ****** ysis showed statistical significance at p
Evommune, Inc. (NYSE:EVMN) had already discontinued EVO756 for chronic spontaneous urticaria following a June trial failure. Development continues in migraine prevention. The setbacks place greater weight on EVO301, which has positive Phase 2a eczema data and a Phase 2b study planned for mid-2027.
Evommune, Inc. (NYSE:EVMN) has clinical evidence supporting its next eczema program. In February, the company reported that EVO301 met the primary endpoint in a randomized, double-blind, placebo-controlled Phase 2a trial involving 70 adults. Participants received two intravenous doses or placebo over a 12-week study.
Evommune, Inc. (NYSE:EVMN) reported a 55% EASI reduction with EVO301 versus 22% with placebo at week 12, a difference of 33 percentage points. The study met its prespecified Bayesian success criterion, and a separate conventional ****** ysis showed statistical significance at p
23 days ago
Saudi Arabia's oil supply crisis is rapidly becoming Europe's problem.
The September 10 attacks on Saudi Arabia's East-West Pipeline struck the system at multiple locations and damaged at least one pumping station, forcing Riyadh to shut down the Kingdom's critical alternative to the Strait of Hormuz.
The 1,200-kilometer Petroline can carry around 7 million barrels per day from Saudi Arabia's eastern producing regions to Yanbu on the Red Sea. Since the war effectively closed Hormuz, it has become one of the most important pieces of energy infrastructure in the world.
Kpler estimates the pipeline had been moving roughly 4 million bpd around Hormuz before the attack. A prolonged outage could ultimately threaten 3.5–4 million bpd of Saudi crude exports. The figure is below Petroline's nameplate capacity because Saudi Arabia can still export some crude from eastern terminals such as Ras Tanura, despite the severe constraints on Gulf shipping.
The immediate problem is storage.
#hormuz #crude
The September 10 attacks on Saudi Arabia's East-West Pipeline struck the system at multiple locations and damaged at least one pumping station, forcing Riyadh to shut down the Kingdom's critical alternative to the Strait of Hormuz.
The 1,200-kilometer Petroline can carry around 7 million barrels per day from Saudi Arabia's eastern producing regions to Yanbu on the Red Sea. Since the war effectively closed Hormuz, it has become one of the most important pieces of energy infrastructure in the world.
Kpler estimates the pipeline had been moving roughly 4 million bpd around Hormuz before the attack. A prolonged outage could ultimately threaten 3.5–4 million bpd of Saudi crude exports. The figure is below Petroline's nameplate capacity because Saudi Arabia can still export some crude from eastern terminals such as Ras Tanura, despite the severe constraints on Gulf shipping.
The immediate problem is storage.
#hormuz #crude
24 days ago
By Katharine Jackson and Mike Scarcella
WASHINGTON, Sept 17 (Reuters) - A federal judge ordered President Donald Trump's administration on Thursday to provide at least 30 days' notice before taking any steps to demolish the Kennedy Center, the landmark performing arts venue that has become a flashpoint in his efforts to reshape the U.S. capital.
U.S. District Judge Christopher Cooper issued the order after lawyers for a Democratic congresswoman who is suing to keep the venue open and Trump's name off its facade submitted new evidence citing the Republican president's comments on Wednesday referring to demolishing the Kennedy Center.
"I think that the Trump administration should certainly have recognition. Because frankly, if we don't do that, it's going to close. It'll end up being ripped down," Trump told reporters in North Carolina, referring to putting his name on the facility established by Congress and opened in 1971 as a memorial to slain President John Kennedy.
Matt Floca, the Kennedy Center's Trump-backed executive director, said in a court filing earlier on Thursday that the building was being temporarily closed to ****** s safety risks in areas "exhibiting severe structural deterioration."
#president #venue
WASHINGTON, Sept 17 (Reuters) - A federal judge ordered President Donald Trump's administration on Thursday to provide at least 30 days' notice before taking any steps to demolish the Kennedy Center, the landmark performing arts venue that has become a flashpoint in his efforts to reshape the U.S. capital.
U.S. District Judge Christopher Cooper issued the order after lawyers for a Democratic congresswoman who is suing to keep the venue open and Trump's name off its facade submitted new evidence citing the Republican president's comments on Wednesday referring to demolishing the Kennedy Center.
"I think that the Trump administration should certainly have recognition. Because frankly, if we don't do that, it's going to close. It'll end up being ripped down," Trump told reporters in North Carolina, referring to putting his name on the facility established by Congress and opened in 1971 as a memorial to slain President John Kennedy.
Matt Floca, the Kennedy Center's Trump-backed executive director, said in a court filing earlier on Thursday that the building was being temporarily closed to ****** s safety risks in areas "exhibiting severe structural deterioration."
#president #venue
24 days ago
An **** ysis of recent filings from American politicians shows that Accenture (NYSE: ACN) and Boston Scientific (NYSE: BSX) saw an uptick in purchases from notable politicians. Rep. Gilbert Ray Cisneros, Jr. (D-CA) bought Boston Scientific shares, according to a filing earlier this month. The trade was made on August 18, 2026. Rep. Ro Khanna (D-CA) also bought the stock twice, on August 3 and August 10, 2026, according to a filing filed on September 4, 2026. Neither politician sold Boston Scientific shares in the same period. Cisneros and Khanna were also the two buyers of Accenture shares in July and August.
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#august #NYSE
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#august #NYSE
24 days ago
Tesla, Inc. (NASDAQ:TSLA) spent nearly two years raising anticipation for the Cybercab. When the time arrived on September 3 in Austin, the result was a stock that popped, then rapidly returned all of its gains, and a robotaxi race that still seems to be Alphabet's to lose.
Tesla, Inc. (NASDAQ:TSLA) had its long-awaited Cybercab launch event in Austin, Texas, but it was invitation-only, not livestreamed, and CEO Elon Musk wasn't there. The company's main public update was a 51-second video released on X of the two-seat, steering-wheel-free vehicle roaming city streets and people hailing it by app. Shares rose roughly 5% throughout the session, finishing near $376. By September 4, enthusiasm had waned, with the stock plummeting as much as 6% as investors realized how little the event revealed about deployment timelines, production ramp, or regulatory clearance.
Only 45 Cybercabs were registered in Texas, and Tesla, Inc. (NASDAQ:TSLA) did not seek an NHTSA exemption before deployment, instead self-certifying the Cybercab as compliant with applicable federal safety standards. NHTSA subsequently opened an audit into that certification and has ordered Tesla to provide additional information about the basis for its compliance claims. CNBC summarized the reaction bluntly: the update "underwhelmed" Wall Street, which had been relying on Tesla, Inc. (NASDAQ:TSLA) becoming a strong rival in the robotaxi sector, which Alphabet's Waymo currently leads.
That comparison is at the heart of the story. Waymo has established the operational track record that Tesla, Inc. (NASDAQ:TSLA) is still chasing: more than 4,000 autonomous vehicles across its U.S. fleet and more than 500,000 fully autonomous rides per week.
Wall Street's take on the incident was severely divided along those lines. Despite Tesla's efforts to control the narrative, some ******* ysts, including Gary Black of Future Fund, called the Cybercab debut largely a bust. Others, such as Deepwater ******* et Management's Gene Munster, predicted that Tesla, Inc. (NASDAQ:TSLA) will add approximately 300 Cybercabs in Austin over the next month.
#tesla #NASDAQ #cybercab
Tesla, Inc. (NASDAQ:TSLA) had its long-awaited Cybercab launch event in Austin, Texas, but it was invitation-only, not livestreamed, and CEO Elon Musk wasn't there. The company's main public update was a 51-second video released on X of the two-seat, steering-wheel-free vehicle roaming city streets and people hailing it by app. Shares rose roughly 5% throughout the session, finishing near $376. By September 4, enthusiasm had waned, with the stock plummeting as much as 6% as investors realized how little the event revealed about deployment timelines, production ramp, or regulatory clearance.
Only 45 Cybercabs were registered in Texas, and Tesla, Inc. (NASDAQ:TSLA) did not seek an NHTSA exemption before deployment, instead self-certifying the Cybercab as compliant with applicable federal safety standards. NHTSA subsequently opened an audit into that certification and has ordered Tesla to provide additional information about the basis for its compliance claims. CNBC summarized the reaction bluntly: the update "underwhelmed" Wall Street, which had been relying on Tesla, Inc. (NASDAQ:TSLA) becoming a strong rival in the robotaxi sector, which Alphabet's Waymo currently leads.
That comparison is at the heart of the story. Waymo has established the operational track record that Tesla, Inc. (NASDAQ:TSLA) is still chasing: more than 4,000 autonomous vehicles across its U.S. fleet and more than 500,000 fully autonomous rides per week.
Wall Street's take on the incident was severely divided along those lines. Despite Tesla's efforts to control the narrative, some ******* ysts, including Gary Black of Future Fund, called the Cybercab debut largely a bust. Others, such as Deepwater ******* et Management's Gene Munster, predicted that Tesla, Inc. (NASDAQ:TSLA) will add approximately 300 Cybercabs in Austin over the next month.
#tesla #NASDAQ #cybercab
24 days ago
The U.S. fuel crisis stemming from the ongoing war in Iran has now reached the retail shelf, with Costco Wholesale (COST) nearly doubling the price of its Kirkland Signature full-synthetic motor oil from roughly $30 to $58 per 5-quart two-pack, while simultaneously capping purchases at two units per membership every seven days.
It's an extraordinary move for a retailer whose entire brand identity rests on bulk buying at deep discounts, and it signals that severe supply chain disruptions are spreading well beyond the gasoline pump.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Crude Prices Soar as Global Oil Supplies Continue to Tighten
Middle East Supply Constraints Lift Crude Oil Prices
#supply #wholesale
It's an extraordinary move for a retailer whose entire brand identity rests on bulk buying at deep discounts, and it signals that severe supply chain disruptions are spreading well beyond the gasoline pump.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Crude Prices Soar as Global Oil Supplies Continue to Tighten
Middle East Supply Constraints Lift Crude Oil Prices
#supply #wholesale
25 days ago
A commonly used drug has been linked to a higher risk of death in a new study.
The antibiotic, cefepime, which is used to treat bacterial infections like pneumonia, UTIs and skin infections, is typically administered via injection by healthcare providers in a clinical setting.
Severe side effects may include confusion, decreased consciousness or seizures, especially in older patients and those with kidney problems, among many other common symptoms, according to Mayo Clinic.
Older Adults Taking 5 Or More Prescription Drugs Face Higher Risk Of Death, Study Finds
New research suggests the medication may be ****** ociated with a higher risk of all-cause mortality.
#risk
The antibiotic, cefepime, which is used to treat bacterial infections like pneumonia, UTIs and skin infections, is typically administered via injection by healthcare providers in a clinical setting.
Severe side effects may include confusion, decreased consciousness or seizures, especially in older patients and those with kidney problems, among many other common symptoms, according to Mayo Clinic.
Older Adults Taking 5 Or More Prescription Drugs Face Higher Risk Of Death, Study Finds
New research suggests the medication may be ****** ociated with a higher risk of all-cause mortality.
#risk
25 days ago
An ******* ysis of recent filings from American politicians shows that Accenture (NYSE: ACN) and Boston Scientific (NYSE: BSX) saw an uptick in purchases from notable politicians. Rep. Gilbert Ray Cisneros, Jr. (D-CA) bought Boston Scientific shares, according to a filing earlier this month. The trade was made on August 18, 2026. Rep. Ro Khanna (D-CA) also bought the stock twice, on August 3 and August 10, 2026, according to a filing filed on September 4, 2026. Neither politician sold Boston Scientific shares in the same period. Cisneros and Khanna were also the two buyers of Accenture shares in July and August.
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#accenture
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#accenture
27 days ago
Fourteen years ago, Ken Jouppi, who had operated a charter airplane business in Alaska since the 1970s, agreed to fly a passenger from Fairbanks to Beaver, one of the state's dry jurisdictions. The passenger's luggage included 72 cans of Budweiser and Bud Light, which she planned to share with her husband on his birthday. Although most of the beer was boxed, a six-pack "was packed only in a grocery bag and would have been in plain view to Jouppi as he was loading the airplane," the Alaska Supreme Court noted last year.
State troopers discovered the beer before the plane took off, and Jouppi was convicted of a misdemeanor. The trial court, which concluded that Jouppi had been "willfully blind" to the six-pack, sentenced him to three days in jail and a $1,500 fine. But state law mandated another punishment that was 63 times as severe: forfeiture of Jouppi's $95,000 airplane. Although that penalty seemed grossly disproportionate, the Alaska Supreme Court ruled that it did not violate the Eighth Amendment's ban on excessive fines.
In July, responding to a petition filed by the Institute for Justice, the U.S. Supreme Court agreed to review that decision. It will hear oral argument in Jouppi v. Alaska on December 1. In a brief supporting Jouppi's appeal that it filed last week, the Cato Institute argues that the Alaska Supreme Court erred by failing to consider the gravity of his conduct and the financial consequences of the forfeiture. Both of those factors, Cato attorney Matthew Cavedon says, have been central to the common-law understanding of excessive fines for eight centuries.
"The Eighth Amendment was designed to prevent this kind of abuse by limiting excessive fines," Cavedon writes. "Long before the United States was founded, the common law protected people from extreme monetary penalties. But the Alaska Supreme Court's view is that challenges to excessive fines 'should rarely succeed.' This dismissive view led it to conclude that there is nothing excessive about the forfeiture of an airplane worth 'only 9.5 times the maximum fine'—and over 60 times the fine actually imposed. The decision below cannot be reconciled with this Court's precedent or the Excessive Fines Clause's original meaning."
In weighing the proportionality of the airplane forfeiture, the Alaska Supreme Court thought the relevant consideration was the harm caused by excessive drinking. "Alcohol abuse in rural Alaska leads to increased crime; disorders, such as alcoholism; conditions, such as fetal alcohol spectrum disorder; and death, imposing substantial costs on public health and the administration of justice," Justice Jude Pate wrote in the majority opinion. "Within this context, it is clear that the illegal importation of even a six-pack of beer causes grave societal harm."
#court #excessive #jouppi
State troopers discovered the beer before the plane took off, and Jouppi was convicted of a misdemeanor. The trial court, which concluded that Jouppi had been "willfully blind" to the six-pack, sentenced him to three days in jail and a $1,500 fine. But state law mandated another punishment that was 63 times as severe: forfeiture of Jouppi's $95,000 airplane. Although that penalty seemed grossly disproportionate, the Alaska Supreme Court ruled that it did not violate the Eighth Amendment's ban on excessive fines.
In July, responding to a petition filed by the Institute for Justice, the U.S. Supreme Court agreed to review that decision. It will hear oral argument in Jouppi v. Alaska on December 1. In a brief supporting Jouppi's appeal that it filed last week, the Cato Institute argues that the Alaska Supreme Court erred by failing to consider the gravity of his conduct and the financial consequences of the forfeiture. Both of those factors, Cato attorney Matthew Cavedon says, have been central to the common-law understanding of excessive fines for eight centuries.
"The Eighth Amendment was designed to prevent this kind of abuse by limiting excessive fines," Cavedon writes. "Long before the United States was founded, the common law protected people from extreme monetary penalties. But the Alaska Supreme Court's view is that challenges to excessive fines 'should rarely succeed.' This dismissive view led it to conclude that there is nothing excessive about the forfeiture of an airplane worth 'only 9.5 times the maximum fine'—and over 60 times the fine actually imposed. The decision below cannot be reconciled with this Court's precedent or the Excessive Fines Clause's original meaning."
In weighing the proportionality of the airplane forfeiture, the Alaska Supreme Court thought the relevant consideration was the harm caused by excessive drinking. "Alcohol abuse in rural Alaska leads to increased crime; disorders, such as alcoholism; conditions, such as fetal alcohol spectrum disorder; and death, imposing substantial costs on public health and the administration of justice," Justice Jude Pate wrote in the majority opinion. "Within this context, it is clear that the illegal importation of even a six-pack of beer causes grave societal harm."
#court #excessive #jouppi
27 days ago
(NewsNation) — A new study found that a rare but serious brain condition has been identified in a small number of people taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound.
Wernicke encephalopathy is a rare neurological disorder caused by a severe deficiency of vitamin B1, also known as thiamine.
GLP-1 prescriptions for kids up more than 30,000% since 2019
Researchers identified 15 cases reported in 2023 and 2024 among people taking GLP-1 medications containing semaglutide, found in Ozempic and Wegovy, or tirzepatide, found in Mounjaro and Zepbound.
Vitamin B1 is essential for proper nerve function. Without enough of it, patients can develop confusion, problems with balance and coordination, and abnormal eye movements.
#zepbound #vitamin #identified
Wernicke encephalopathy is a rare neurological disorder caused by a severe deficiency of vitamin B1, also known as thiamine.
GLP-1 prescriptions for kids up more than 30,000% since 2019
Researchers identified 15 cases reported in 2023 and 2024 among people taking GLP-1 medications containing semaglutide, found in Ozempic and Wegovy, or tirzepatide, found in Mounjaro and Zepbound.
Vitamin B1 is essential for proper nerve function. Without enough of it, patients can develop confusion, problems with balance and coordination, and abnormal eye movements.
#zepbound #vitamin #identified
29 days ago
During the September 8 episode of Mad Money, Jim Cramer turned his attention to Enbridge Inc. (NYSE:ENB), examining escalating geopolitical tensions. He commented:
As long as the war with Iran drags on, it's easy to recommend the refiners like a Valero or a Marathon. I don't see it ending any time soon, not with the US and Iran trading volleys this evening at islands and ships in the Strait. But how about a pipeline that moves about 30% of all crude produced in North America? Now, I'm talking about Enbridge which has a 5.5% yield. Also has a natural gas, you know, it transports 20% of the natural gas that's consumed in America. Okay, it's Canadian, but it's not caught up in the tariff fight because slapping tariffs on Canadian energy would be economic suicide for our country.
Cramer's focus on Enbridge Inc. (NYSE:ENB) highlights the structural dominance of its midstream network. The company operates as a significant transport network for North American energy, moving approximately 30% of all crude produced on the continent. Moreover, its vast utility and transmission network handles 20% of the natural gas consumed in the United States. The company's toll-road business model generates highly predictable cash flows, supporting an attractive dividend yield of roughly 5.6%. For income-focused investors, the combination of essential operational volume and reliable capital return creates a defensive cushion during volatile market cycles.
The company's defensive moat goes into cross-border trade and regional security. As Cramer pointed out, imposing punitive tariffs on Canadian energy imports would amount to severe economic self-harm for the United States, given the deep interdependence of North American energy grids.
Even with steady toll revenues, Enbridge Inc. (NYSE:ENB) carries a heavy debt load that comes with the territory of running massive pipeline networks, with long-term debt sitting at approximately C$104 billion. Because building and maintaining energy infrastructure requires heavy borrowing, higher interest rates hit financing costs, which can occasionally weigh on income-seeking investors.
#enbridge #natural #Iran #America
As long as the war with Iran drags on, it's easy to recommend the refiners like a Valero or a Marathon. I don't see it ending any time soon, not with the US and Iran trading volleys this evening at islands and ships in the Strait. But how about a pipeline that moves about 30% of all crude produced in North America? Now, I'm talking about Enbridge which has a 5.5% yield. Also has a natural gas, you know, it transports 20% of the natural gas that's consumed in America. Okay, it's Canadian, but it's not caught up in the tariff fight because slapping tariffs on Canadian energy would be economic suicide for our country.
Cramer's focus on Enbridge Inc. (NYSE:ENB) highlights the structural dominance of its midstream network. The company operates as a significant transport network for North American energy, moving approximately 30% of all crude produced on the continent. Moreover, its vast utility and transmission network handles 20% of the natural gas consumed in the United States. The company's toll-road business model generates highly predictable cash flows, supporting an attractive dividend yield of roughly 5.6%. For income-focused investors, the combination of essential operational volume and reliable capital return creates a defensive cushion during volatile market cycles.
The company's defensive moat goes into cross-border trade and regional security. As Cramer pointed out, imposing punitive tariffs on Canadian energy imports would amount to severe economic self-harm for the United States, given the deep interdependence of North American energy grids.
Even with steady toll revenues, Enbridge Inc. (NYSE:ENB) carries a heavy debt load that comes with the territory of running massive pipeline networks, with long-term debt sitting at approximately C$104 billion. Because building and maintaining energy infrastructure requires heavy borrowing, higher interest rates hit financing costs, which can occasionally weigh on income-seeking investors.
#enbridge #natural #Iran #America
29 days ago
Extreme weather is creating a more demanding environment for property owners, insurers, and communities. According to the National Centers for Environmental Information (NCEI), the United States recorded 27 confirmed billion-dollar weather and climate disasters in 2024, resulting in a total cost of $182.7 billion. These events spanned a wide range of extremes, including severe storm events, tropical cyclones, wildfires, drought/heat waves, and winter storm/cold wave events. Over the last decade, ***** ulative losses from these disasters have exceeded $1.4 trillion, driven significantly by population growth, material wealth, and increased development in hazard-prone areas. These figures suggest that the financial consequences of extreme events may increasingly depend on how accurately the value of exposed property is understood before a loss occurs.
That question becomes especially consequential during reconstruction. A 2026 report from Bloomberg, featured in Claims Journal, noted that surveys conducted by United Policyholders since 2007 found an average of two-thirds of wildfire survivors reporting that they were underinsured, with an average shortfall of $200,000 or more. The Insurance Information Institute has similarly estimated that two-thirds of American homeowners may be underinsured for wildfire losses, typically by about 20%, and in some cases by as much as 60%. These findings illustrate how the presence of an insurance policy can still leave a substantial difference between available coverage and the resources required to rebuild, particularly when construction costs rise after a catastrophe.
The financial implications can extend across the broader insurance ecosystem. Aon's 2026 Climate and Catastrophe Insight reported approximately $260 billion in global economic losses from natural catastrophes during 2025, compared with $127 billion in insured losses. For property stakeholders, such a figure may place greater attention on the relationship between the value ***** igned to an ***** et, the cost of restoring it, and the capital available when a loss occurs.
Frequency can add another layer to that calculation. Data from NCEI indicate that the average interval between U.S. billion-dollar disaster events was approximately 16 days during 2020–2024, compared with 82 days during the 1980s. NCEI notes that shorter intervals can leave less time and fewer resources for response, recovery, and preparation for subsequent events. As the time between major events contracts, property valuations may require more frequent attention because construction costs, labor conditions, materials, and local economic circumstances can change between policy reviews.
#property #losses #insurance #information
That question becomes especially consequential during reconstruction. A 2026 report from Bloomberg, featured in Claims Journal, noted that surveys conducted by United Policyholders since 2007 found an average of two-thirds of wildfire survivors reporting that they were underinsured, with an average shortfall of $200,000 or more. The Insurance Information Institute has similarly estimated that two-thirds of American homeowners may be underinsured for wildfire losses, typically by about 20%, and in some cases by as much as 60%. These findings illustrate how the presence of an insurance policy can still leave a substantial difference between available coverage and the resources required to rebuild, particularly when construction costs rise after a catastrophe.
The financial implications can extend across the broader insurance ecosystem. Aon's 2026 Climate and Catastrophe Insight reported approximately $260 billion in global economic losses from natural catastrophes during 2025, compared with $127 billion in insured losses. For property stakeholders, such a figure may place greater attention on the relationship between the value ***** igned to an ***** et, the cost of restoring it, and the capital available when a loss occurs.
Frequency can add another layer to that calculation. Data from NCEI indicate that the average interval between U.S. billion-dollar disaster events was approximately 16 days during 2020–2024, compared with 82 days during the 1980s. NCEI notes that shorter intervals can leave less time and fewer resources for response, recovery, and preparation for subsequent events. As the time between major events contracts, property valuations may require more frequent attention because construction costs, labor conditions, materials, and local economic circumstances can change between policy reviews.
#property #losses #insurance #information
29 days ago
It wasn't pretty, but Arizona volleyball found a way to end its five-game losing streak with a victory over Oregon State on Saturday. The Wildcats won 3-1 (25-23, 25-23, 16-25, 27-25) at the Galen Center in Los Angeles, Calif.
"It was necessary for us to win that match," said Arizona head coach Rita Stubbs.
It was a struggle throughout. Arizona had difficulty scoring and Oregon State had success against the Wildcats' block. While Arizona had nine blocks, it also had four blocking errors on the day. The Wildcats only had nine blocking errors in seven matches this season prior to Saturday.
Things were tight in the sets Arizona won. The Beavers took a late lead in all three before Arizona came back. The third set, which Oregon State won, was even less competitive than the 25-16 score suggested. The Wildcats persevered and Stubbs used her bench when she needed to.
Destiny Ndam-Simpson leads the Wildcats with 3.42 kills per set this season, but Saturday wasn't her day. The Beavers kept her in check, regularly taking her out of the play with their serve. She received 24 serves despite being subbed out halfway through the third set and not returning. Only Carlie Cisneros with 25 receptions in four sets was targeted more. Four of the Beavers' seven aces were charged to Ndam-Simpson.
#oregon #stubbs
"It was necessary for us to win that match," said Arizona head coach Rita Stubbs.
It was a struggle throughout. Arizona had difficulty scoring and Oregon State had success against the Wildcats' block. While Arizona had nine blocks, it also had four blocking errors on the day. The Wildcats only had nine blocking errors in seven matches this season prior to Saturday.
Things were tight in the sets Arizona won. The Beavers took a late lead in all three before Arizona came back. The third set, which Oregon State won, was even less competitive than the 25-16 score suggested. The Wildcats persevered and Stubbs used her bench when she needed to.
Destiny Ndam-Simpson leads the Wildcats with 3.42 kills per set this season, but Saturday wasn't her day. The Beavers kept her in check, regularly taking her out of the play with their serve. She received 24 serves despite being subbed out halfway through the third set and not returning. Only Carlie Cisneros with 25 receptions in four sets was targeted more. Four of the Beavers' seven aces were charged to Ndam-Simpson.
#oregon #stubbs
29 days ago
At the end of Stage 1, the NASCAR O'Reilly Auto Parts Series field filed down pit road for standard pit stops, but things quickly went very wrong.
On the narrow pit road, there was a check-up that led to Rajah Caruth and Nick Sanchez spinning. It was an accordion effect as cars piled in, pushing each other into the wreck.
Caruth's car clipped crew members of Brent Crews' No. 19 Joe Gibbs Racing, who also narrowly avoided being crushed by Sanchez's out-of-control car. It was a truly frightening moment that could have resulted in severe injuries, but thankfully, everyone was okay.
That was such a close call for Bryan Backus on the rear of the No. 19.
So glad to see him get up. pic.twitter.com/duFSFNxVnz
Most of the field was trapped behind the accident scene, unable to move. NASCAR was forced to immediately red flag the race.
#stage #caruth
On the narrow pit road, there was a check-up that led to Rajah Caruth and Nick Sanchez spinning. It was an accordion effect as cars piled in, pushing each other into the wreck.
Caruth's car clipped crew members of Brent Crews' No. 19 Joe Gibbs Racing, who also narrowly avoided being crushed by Sanchez's out-of-control car. It was a truly frightening moment that could have resulted in severe injuries, but thankfully, everyone was okay.
That was such a close call for Bryan Backus on the rear of the No. 19.
So glad to see him get up. pic.twitter.com/duFSFNxVnz
Most of the field was trapped behind the accident scene, unable to move. NASCAR was forced to immediately red flag the race.
#stage #caruth
30 days ago
Nyxoah SA (NASDAQ:NYXH) announced the first patient implantation in BREATHE on September 7. The prospective, single-arm U.S. post-approval study will evaluate Genio hypoglossal-nerve stimulation in adults aged 22 or older with moderate to severe obstructive sleep apnea for whom standard-care treatments have failed, cannot be tolerated, or are unsuitable. Plans call for up to 229 patients at up to 25 centers, with follow-up lasting up to five years.
For Nyxoah SA (NASDAQ:NYXH), the milestone begins a new phase of evidence collection following Genio's August 2025 FDA approval. The co-primary effectiveness endpoints are apnea-hypopnea-index and oxygen-desaturation-index responder rates at 12 months. Device- and procedure-related serious adverse events will be **** sed at 12 months and annually thereafter. The investment question is whether that evidence can help turn clinical credibility into sustained commercial adoption.
Nyxoah SA (NASDAQ:NYXH) has an opportunity to demonstrate how Genio performs across different physicians and treatment settings. Consistent outcomes across participating centers could give referring sleep physicians and implanting surgeons greater confidence in patient selection and treatment delivery.
The product offers a distinct approach. Genio stimulates hypoglossal nerves on both sides of the tongue, using a battery-free implant powered by an external wearable. For Nyxoah SA (NASDAQ:NYXH), documenting effectiveness and safety in routine practice could help physicians **** s how that design fits their patients' needs.
Longer follow-up could also strengthen the evidence available to payers. Nyxoah SA (NASDAQ:NYXH) could use sustained responses and safety findings to support coverage discussions, while participating centers gain practical experience with implantation and follow-up. That would make BREATHE valuable beyond a single headline response rate.
#nyxoah #NASDAQ #nyxh
For Nyxoah SA (NASDAQ:NYXH), the milestone begins a new phase of evidence collection following Genio's August 2025 FDA approval. The co-primary effectiveness endpoints are apnea-hypopnea-index and oxygen-desaturation-index responder rates at 12 months. Device- and procedure-related serious adverse events will be **** sed at 12 months and annually thereafter. The investment question is whether that evidence can help turn clinical credibility into sustained commercial adoption.
Nyxoah SA (NASDAQ:NYXH) has an opportunity to demonstrate how Genio performs across different physicians and treatment settings. Consistent outcomes across participating centers could give referring sleep physicians and implanting surgeons greater confidence in patient selection and treatment delivery.
The product offers a distinct approach. Genio stimulates hypoglossal nerves on both sides of the tongue, using a battery-free implant powered by an external wearable. For Nyxoah SA (NASDAQ:NYXH), documenting effectiveness and safety in routine practice could help physicians **** s how that design fits their patients' needs.
Longer follow-up could also strengthen the evidence available to payers. Nyxoah SA (NASDAQ:NYXH) could use sustained responses and safety findings to support coverage discussions, while participating centers gain practical experience with implantation and follow-up. That would make BREATHE valuable beyond a single headline response rate.
#nyxoah #NASDAQ #nyxh
30 days ago
FirstEnergy Corp. (NYSE:FE), through its Potomac Edison subsidiary, proposed a $52.8 million Maryland distribution-rate adjustment to support investment in aging infrastructure, grid modernization and electric-system reliability. If approved, the request would increase the average residential customer's monthly bill by approximately 5.3%.
Potomac Edison said its electric rates were 25% below the average of its in-state peers as of June 1. The utility expects its residential rates to remain the lowest among Maryland's investor-owned electric utilities even after the proposed adjustment.
The proposed reliability program includes Supervisory Control and Data Acquisition technology, replacement of substation reclosers, new circuit ties and automation, overhead-conductor upgrades, aging underground-cable replacement and removal of high-risk trees near power lines. The Maryland Public Service Commission must review and approve the request before any adjustment can take effect.
The proposal connects the requested revenue to specific reliability investments. SCADA technology can give operators greater visibility into system conditions, while reclosers, circuit ties, and automation can isolate problems and reroute electricity. These capabilities can reduce the number of customers affected by outages and shorten restoration times.
Reconductoring, underground-cable replacement and vegetation management address physical causes of service interruptions. The investments could also improve resilience during severe weather, potentially lowering emergency-response costs and reducing the disruption experienced by customers.
#proposed #maryland #aging
Potomac Edison said its electric rates were 25% below the average of its in-state peers as of June 1. The utility expects its residential rates to remain the lowest among Maryland's investor-owned electric utilities even after the proposed adjustment.
The proposed reliability program includes Supervisory Control and Data Acquisition technology, replacement of substation reclosers, new circuit ties and automation, overhead-conductor upgrades, aging underground-cable replacement and removal of high-risk trees near power lines. The Maryland Public Service Commission must review and approve the request before any adjustment can take effect.
The proposal connects the requested revenue to specific reliability investments. SCADA technology can give operators greater visibility into system conditions, while reclosers, circuit ties, and automation can isolate problems and reroute electricity. These capabilities can reduce the number of customers affected by outages and shorten restoration times.
Reconductoring, underground-cable replacement and vegetation management address physical causes of service interruptions. The investments could also improve resilience during severe weather, potentially lowering emergency-response costs and reducing the disruption experienced by customers.
#proposed #maryland #aging
30 days ago
For months, rumors about influencer Charli D'Amelio's relationship with her family have been circulating online, and a recent appearance on Quenlin Blackwell's "Feeding Starving Celebrities" video series seems to have added more fuel to that fire.
In the video uploaded on Sept. 5, D'Amelio, the second-most followed TikToker with close to 160 million followers, starts the episode by surprising Blackwell with a pair of sweatpants from her merch store. As they're talking about her many business ventures, Blackwell then asks her how much money she made from her merch. "Mmm, ain't that the question," D'Amelio responds as she looks into the camera and laughs as she adds, "Wouldn't I like to know."
This comes three months after People confirmed that she is no longer involved in the family's popcorn brand, Be Happy Snacks, and the publication reported that the severed ties are allegedly a result of a financial dispute between her and her parents, Marc and Heidi D'Amelio. A representative for the brand told TMZ that her decision to bow out of the family business was "a formal amicable separation from D'Amelio Brands and D'Amelio Family LLC that everyone agreed to at the time."
TMZ also reported that the separation began in March 2025 and was made official in November 2025, meaning she was out of the company for more than six months before the news broke.
USA TODAY reached out to representatives for Charli D'Amelio and her family for this story, but did not hear back.
#blackwell #brand
In the video uploaded on Sept. 5, D'Amelio, the second-most followed TikToker with close to 160 million followers, starts the episode by surprising Blackwell with a pair of sweatpants from her merch store. As they're talking about her many business ventures, Blackwell then asks her how much money she made from her merch. "Mmm, ain't that the question," D'Amelio responds as she looks into the camera and laughs as she adds, "Wouldn't I like to know."
This comes three months after People confirmed that she is no longer involved in the family's popcorn brand, Be Happy Snacks, and the publication reported that the severed ties are allegedly a result of a financial dispute between her and her parents, Marc and Heidi D'Amelio. A representative for the brand told TMZ that her decision to bow out of the family business was "a formal amicable separation from D'Amelio Brands and D'Amelio Family LLC that everyone agreed to at the time."
TMZ also reported that the separation began in March 2025 and was made official in November 2025, meaning she was out of the company for more than six months before the news broke.
USA TODAY reached out to representatives for Charli D'Amelio and her family for this story, but did not hear back.
#blackwell #brand
1 month ago
It started with yelling about toilets. Steve Ballmer was so serious about turning the Los Angeles Clippers into a serious franchise for the first time in their existence that he wanted to make sure no fan ever waited in a long line to use the bathroom when the team opened its new arena. Ballmer's drive to win eventually led the Clippers to courting Kawhi Leonard in free agency, fresh off leading the Toronto Raptors to a 2019 NBA championship. Leonard wanted to live in Los Angeles, yes, but he also wanted Paul George as his running mate, so the Clippers shipped out a boatload of draft picks and future two-time MVP Shai Gilgeous-Alexander to get him.
Leonard's people also made it known that their client wanted the type of big endorsement deals his off-putting, robotic personality couldn't land legitimately. Leonard's now infamous Uncle Dennis Robertson never tried to be subtle about his desire to secure similar off-court bags to the ones Kawhi's contemporaries like LeBron James, Steph Curry, and Kevin Durant were landing on their own accord, and leaks of his demands circulated as soon as Leonard hit free agency.
The Clippers became so entangled in pleasing Leonard that it led to blatant salary cap circumvention, first reported by investigative journalist Pablo Torre. The NBA found enough evidence supporting Torre's claims that it hammered the Clippers with the most severe penalty in league history, stripping five future first-round draft picks, suspending executives including Ballmer, and more. That figured to be the end of the story, with the Clippers spending the next decade trying to climb out of the abyss. Torre continued to hint that there was another shoe to drop, and now that it's here, the Clippers might be in much bigger trouble than anyone first believed.
The Department of Justice has opened a criminal investigation into the Clippers, according to the New York Times, and it's already issued one subpoena. While the scope of the investigation is unclear for now, the fact that the feds are watching the Clippers for under-the-table dealings potentially makes this a much bigger deal than simply breaking NBA rules.
How does breaking NBA rules amount to a federal crime by the Clippers? While there's a lot left to come out, the main idea is that the Clippers committed some level of fraud. Daktronics was a publicly traded company, the only one of the four tied up in the Leonard scandal to fit that description, while Aspiration, Lockton Insurance, and Boingo Wireless were not. Publicly traded companies have a fiduciary duty to their shareholders to disclose big investments, and it sure feels like that never happened when dealing with Leonard.
#ballmer
Leonard's people also made it known that their client wanted the type of big endorsement deals his off-putting, robotic personality couldn't land legitimately. Leonard's now infamous Uncle Dennis Robertson never tried to be subtle about his desire to secure similar off-court bags to the ones Kawhi's contemporaries like LeBron James, Steph Curry, and Kevin Durant were landing on their own accord, and leaks of his demands circulated as soon as Leonard hit free agency.
The Clippers became so entangled in pleasing Leonard that it led to blatant salary cap circumvention, first reported by investigative journalist Pablo Torre. The NBA found enough evidence supporting Torre's claims that it hammered the Clippers with the most severe penalty in league history, stripping five future first-round draft picks, suspending executives including Ballmer, and more. That figured to be the end of the story, with the Clippers spending the next decade trying to climb out of the abyss. Torre continued to hint that there was another shoe to drop, and now that it's here, the Clippers might be in much bigger trouble than anyone first believed.
The Department of Justice has opened a criminal investigation into the Clippers, according to the New York Times, and it's already issued one subpoena. While the scope of the investigation is unclear for now, the fact that the feds are watching the Clippers for under-the-table dealings potentially makes this a much bigger deal than simply breaking NBA rules.
How does breaking NBA rules amount to a federal crime by the Clippers? While there's a lot left to come out, the main idea is that the Clippers committed some level of fraud. Daktronics was a publicly traded company, the only one of the four tied up in the Leonard scandal to fit that description, while Aspiration, Lockton Insurance, and Boingo Wireless were not. Publicly traded companies have a fiduciary duty to their shareholders to disclose big investments, and it sure feels like that never happened when dealing with Leonard.
#ballmer
1 month ago
On August 27, AstraZeneca PLC (NYSE:AZN) and Amgen Inc. (NASDAQ:AMGN) scored a shared clinical victory. Positive high-level results from the Phase III CROSSING trial showed that their co-developed severe asthma drug, TEZSPIRE, achieved statistically significant and clinically meaningful improvements across both co-primary endpoints, histologic remission and the frequency/severity of dysphagia, and all key secondary endpoints at week 24 in patients with eosinophilic esophagitis. These benefits were sustained through week 52 across both tested doses, accompanied by a safety profile consistent with its approved indications. While CROSSING highlights their joint R&D success, a closer look at their standalone financial performance reveals distinct growth trajectories.
Both pharmaceutical giants delivered solid Q2 2026 results, but AstraZeneca is showing stronger overall financial momentum. AstraZeneca PLC (NYSE:AZN)'s Q2 revenue increased 6% year over year to $15.38 billion, supported by its Oncology franchise, which grew 18% in H1 to $14.12 billion, and its Rare Disease portfolio, which increased 13%. Core EPS rose 21% to $2.63, beating expectations, while management reaffirmed its full-year 2026 outlook for mid-to-high single-digit revenue growth and low double-digit Core EPS growth.
Amgen Inc. (NASDAQ:AMGN) reported Q2 revenue of $10.1 billion, up 10% year over year, while non-GAAP EPS increased 4% to $6.29. Although its key growth products advanced 26%, mature products faced significant biosimilar pressure, with Prolia revenue declining 32% and XGEVA falling 34%. Amgen nevertheless raised its 2026 revenue guidance midpoint to $39.4 billion.
Overall, AZN holds the financial edge due to stronger EPS growth, broader portfolio momentum, and less exposure to the biosimilar erosion affecting AMGN's mature products.
Amgen's bull case is supported by robust growth in key products, which increased 26%, and $3.5 billion in Q2 free cash flow, providing substantial capital flexibility. Wells Fargo raised its Amgen price target to $435 from $400 on September 4, citing potential upside from HORIZON and pipeline ****** ets such as olpasiran. New Phase III VESALIUS-CV data also showed Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke, with heart attack risk reductions emerging as early as six months. However, accelerating biosimilar competition affecting legacy franchises such as Prolia and XGEVA remains a key risk to sustained margin expansion.
#revenue #astrazeneca #increased #products
Both pharmaceutical giants delivered solid Q2 2026 results, but AstraZeneca is showing stronger overall financial momentum. AstraZeneca PLC (NYSE:AZN)'s Q2 revenue increased 6% year over year to $15.38 billion, supported by its Oncology franchise, which grew 18% in H1 to $14.12 billion, and its Rare Disease portfolio, which increased 13%. Core EPS rose 21% to $2.63, beating expectations, while management reaffirmed its full-year 2026 outlook for mid-to-high single-digit revenue growth and low double-digit Core EPS growth.
Amgen Inc. (NASDAQ:AMGN) reported Q2 revenue of $10.1 billion, up 10% year over year, while non-GAAP EPS increased 4% to $6.29. Although its key growth products advanced 26%, mature products faced significant biosimilar pressure, with Prolia revenue declining 32% and XGEVA falling 34%. Amgen nevertheless raised its 2026 revenue guidance midpoint to $39.4 billion.
Overall, AZN holds the financial edge due to stronger EPS growth, broader portfolio momentum, and less exposure to the biosimilar erosion affecting AMGN's mature products.
Amgen's bull case is supported by robust growth in key products, which increased 26%, and $3.5 billion in Q2 free cash flow, providing substantial capital flexibility. Wells Fargo raised its Amgen price target to $435 from $400 on September 4, citing potential upside from HORIZON and pipeline ****** ets such as olpasiran. New Phase III VESALIUS-CV data also showed Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke, with heart attack risk reductions emerging as early as six months. However, accelerating biosimilar competition affecting legacy franchises such as Prolia and XGEVA remains a key risk to sustained margin expansion.
#revenue #astrazeneca #increased #products
1 month ago
The pharmaceutical sector was hit with major pipeline news on September 1 when Novartis AG (NYSE:NVS) paused eight clinical trials of rap-cel, its experimental CAR-T cell therapy targeting autoimmune and neurological disorders. The suspension, effective August 24, followed three patient deaths caused by severe, life-threatening immune reactions (immune effector cell-associated hemophagocytic syndrome). Novartis is currently conducting a safety review alongside independent monitoring boards. Following the news, Bristol-Myers Squibb Company (NYSE:BMY) voluntarily paused trials for its competing CAR-T treatment, zola-cel, as a precautionary measure after detecting transient inflammatory side effects.
Looking at Q2 2026 earnings, Bristol Myers Squibb is currently demonstrating stronger financial momentum. Bristol-Myers Squibb Company (NYSE:BMY) reported total revenue of $13.0 billion, up 6% year over year, driven by a 15% increase in its Growth Portfolio to $7.6 billion, led by Opdivo, Qvantig, Reblozyl, and Camzyos. Non-GAAP EPS reached $2.04, while net income totaled $3.3 billion, or $4.2 billion on a non-GAAP basis. The company also raised its full-year 2026 revenue guidance from approximately $46.0–$47.5 billion to $49.0–$50.0 billion and increased its non-GAAP EPS outlook to $6.75–$7.00.
Novartis AG (NYSE:NVS), meanwhile, reported Q2 net sales of $14.4 billion, up 3% in U.S. dollars and 1% at constant currencies, supported by Kisqali and Kesimpta, which grew 43% and 32% at constant currencies, respectively. However, generic competition reduced growth by 14 percentage points, while core operating income remained flat at $5.9 billion and GAAP net income fell 19% to $3.3 billion. Novartis reaffirmed rather than raised its full-year guidance, calling for low single-digit sales growth and a low single-digit decline in core operating income.
Overall, Bristol Myers stands out as the stronger financial story this quarter, with its Growth Portfolio offsetting legacy patent-cliff pressures and supporting a guidance increase, while Novartis continues to contend with generic erosion weighing on earnings.
Novartis' bull case rests on strong double-digit growth from high-margin blockbusters such as Kisqali, Kesimpta, and Scemblix, supporting robust Q2 free cash flow of $5.6 billion. However, CAR-T safety setbacks could threaten a key pipeline platform, while intense generic competition has already reduced top-line growth by 14 percentage points.
#billion #novartis
Looking at Q2 2026 earnings, Bristol Myers Squibb is currently demonstrating stronger financial momentum. Bristol-Myers Squibb Company (NYSE:BMY) reported total revenue of $13.0 billion, up 6% year over year, driven by a 15% increase in its Growth Portfolio to $7.6 billion, led by Opdivo, Qvantig, Reblozyl, and Camzyos. Non-GAAP EPS reached $2.04, while net income totaled $3.3 billion, or $4.2 billion on a non-GAAP basis. The company also raised its full-year 2026 revenue guidance from approximately $46.0–$47.5 billion to $49.0–$50.0 billion and increased its non-GAAP EPS outlook to $6.75–$7.00.
Novartis AG (NYSE:NVS), meanwhile, reported Q2 net sales of $14.4 billion, up 3% in U.S. dollars and 1% at constant currencies, supported by Kisqali and Kesimpta, which grew 43% and 32% at constant currencies, respectively. However, generic competition reduced growth by 14 percentage points, while core operating income remained flat at $5.9 billion and GAAP net income fell 19% to $3.3 billion. Novartis reaffirmed rather than raised its full-year guidance, calling for low single-digit sales growth and a low single-digit decline in core operating income.
Overall, Bristol Myers stands out as the stronger financial story this quarter, with its Growth Portfolio offsetting legacy patent-cliff pressures and supporting a guidance increase, while Novartis continues to contend with generic erosion weighing on earnings.
Novartis' bull case rests on strong double-digit growth from high-margin blockbusters such as Kisqali, Kesimpta, and Scemblix, supporting robust Q2 free cash flow of $5.6 billion. However, CAR-T safety setbacks could threaten a key pipeline platform, while intense generic competition has already reduced top-line growth by 14 percentage points.
#billion #novartis
